BridgeBio Pharma
BBIO
#2325
Rank
โ‚น544.86 B
Marketcap
โ‚น2,865
Share price
2.04%
Change (1 day)
22.78%
Change (1 year)

Operating Margin for BridgeBio Pharma (BBIO)

Operating Margin as of March 2025 (TTM): -244.33%

According to BridgeBio Pharma 's latest financial reports and stock price the company's current Operating Margin is -244.33%. At the end of 2024 the company had an Operating Margin of -244.34%.

Operating Margin history for BridgeBio Pharma from 2020 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-244.34%-96.52%
2023-7,021.94%1025.01%
2022-624.17%-25.8%
2021-841.20%-86.27%
2020-6,127.87%761.26%
2019-711.50%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-8,391.15% 3,334.35%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.45%-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.